| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |